Emergent management of postpartum hemorrhage for the general and acute care surgeon
© Weisbrod et al; licensee BioMed Central Ltd. 2009
Received: 26 August 2009
Accepted: 25 November 2009
Published: 25 November 2009
Postpartum hemorrhage is one of the rare occasions when a general or acute care surgeon may be emergently called to labor and delivery, a situation in which time is limited and the stakes high. Unfortunately, there is generally a paucity of exposure and information available to surgeons regarding this topic: obstetric training is rarely found in contemporary surgical residency curricula and is omitted nearly completely from general and acute care surgery literature and continuing medical education.
The purpose of this manuscript is to serve as a topic specific review for surgeons and to present a surgeon oriented management algorithm. Medline and Ovid databases were utilized in a comprehensive literature review regarding the management of postpartum hemorrhage and a management algorithm for surgeons developed based upon a collaborative panel of general, acute care, trauma and obstetrical surgeons' review of the literature and expert opinion.
A stepwise approach for surgeons of the medical and surgical interventions utilized to manage and treat postpartum hemorrhage is presented and organized into a basic algorithm.
The manuscript should promote and facilitate a more educated, systematic and effective surgeon response and participation in the management of postpartum hemorrhage.
Postpartum hemorrhage (PPH) is one of the rare occasions when a general or acute care surgeon may be called to labor and delivery emergently. At the least, this represents entrance into an environment and scenario that for most surgeons is not only foreign but also one in which time is limited and the stakes high. Being prepared to competently participate in the management of severe postpartum hemorrhage necessitates a basic knowledge of pelvic and gynecologic anatomy, the pathophysiology of such hemorrhage and a conceptual algorithm for its management to permit integrated participation with the obstetrical team for efficient and efficacious care of the new mother.
Postpartum hemorrhage may occur in 1-5% of deliveries in developed countries [1, 2], and is still the most significant cause of maternal morbidity and mortality . Blood loss following childbirth will vary depending on the type of delivery: vaginal versus cesarean. Classically, PPH has been defined as a blood loss greater than 500 mL after a vaginal delivery and greater than 1000 mL after a cesarean section. These definitions are flawed in that it is recognized that 500 mL is the average blood loss after a vaginal delivery and 1000 mL is the average blood loss after a cesarean . Underestimation of post-delivery blood loss is not uncommon, and is likely contributed to, at least in part, by the ability of healthy pregnant women to lose up one liter of blood acutely without a noticeable drop in hemoglobin or significant hemodynamic change [4, 5]. A more useful and accepted definition of PPH is defined as blood loss sufficient to cause hypovolemia, a 10% drop in the hematocrit or requiring transfusion of blood products (regardless of the route of delivery) . PPH of this nature may occur in 4% of vaginal deliveries and up to 6% of cesarean deliveries in developed countries [6–8]. Postpartum hemorrhage may develop in patients with no risk factors; however, reported risk factors include: multiparity, operative deliveries (forceps or vacuum assisted deliveries), previous postpartum hemorrhage, antepartum hemorrhage, prolonged third stage of labor (delivery of the placenta more than 30 minutes after delivery of the fetus), abnormal placentation (placenta previa, accreta or increta), oxytocin use, maternal obesity, and a distended uterus (from a large baby, multifetal gestation or excessive amniotic fluid) [6–9]. In developed countries, the maternal mortality of such hemorrhage has been reported to be on the order of 0.1% of all deliveries .
It is the goal of this paper to serve as a refresher and basic fund of knowledge for general surgeons with regard to postpartum hemorrhage so that when called upon to assist in such a scenario, prompt and efficacious assistance may be provided in a spontaneous, educated and systematic manner.
Call to the General/Acute Care Surgeon
Most commonly, the patient is in the operating suite in labor and delivery following a cesarean section and a hysterectomy is being considered or performed for PPH that has not responded to the usual medical and surgical measures. These patients likely will be hemodynamically unstable and may be experiencing latent or full-blown disseminated intravascular coagulation (DIC).
The second most common scenario will be a patient status post a vaginal delivery who is experiencing PPH refractory to medical measures who has been or is being moved to the labor and delivery operating suite for an operative intervention. Similarly, these patients will be in or near significant hemodynamic compromise and DIC.
Lastly, and probably the least likely scenario, is the previous patient, still in the delivery suite. A good number of these patients will respond to medical interventions to control their PPH. This situation is usually handled by obstetrical practitioners, who would try medical measures on their own, or call another obstetrical practitioner.
Once significant postpartum hemorrhage has been recognized, resuscitation is performed in parallel to diagnostic efforts. The initial assessment of the patient should be conducted in much the same manner as per Advanced Trauma Life Support (ATLS) guidelines. Certainly, this should be tailored and should take into account what has been and is already underway; however, "ABCs" must be evaluated with interventions provided as needed. If not already in place, appropriate monitors should be attached and monitoring commenced: Continuous pulse oximetry, heart rate and blood pressure measurements (a minimum of every 5 minutes), and a foley catheter, if not in place, should be placed and utilized to monitor urine output. Initial lab studies should be ordered and repeated as needed and at least every 4 hours, to include type & cross for six units of packed red blood cells (PRBCs), chemistry panel, complete blood count (CBC), coagulation panel, and fibrinogen. Unique to the postpartum patient, D-Dimer studies may be sent; however interpretation must take into account that pregnancy itself results in elevated values, therefore limiting its utility . At a minimum two large bore IVs (14 gauge) should be in place and if necessary, central intravenous access and arterial lines should be inserted for central venous pressure monitoring, additional fluid infusion, continuous blood pressure monitoring and ease of subsequent lab draws. Appropriate personnel in the blood bank should be notified early and a massive blood transfusion protocol initiated preemptively if blood transfusions are anticipated.
Fluids should be replaced with the goal of matching all previous losses within the first hour. The rate is then titrated to provide maintenance fluids and make up for continued losses so appropriate vital signs can be maintained. It is prudent to limit fluids to no more than 2 L of crystalloids, 1.5 L of colloid or 2 units of type O-negative blood prior to providing cross-matched blood to the patient . A more accurate assessment of volume loss can be assessed by calculating the patient's blood volume is (8.5-9% of a pregnant woman's body weight) and comparing it to estimated blood loss (determined by changes in pulse, systolic blood pressure and mean arterial pressure) . If bleeding persists with blood loss greater than 40% of estimated patient blood volume, packed red blood cells should be transfused . Early consideration of PRBC transfusion in these patients is warranted due to their baseline moderate hemodilution.
Examination and Initial Interventions
Establishing a cause of hemorrhage is the first step towards correcting the problem. The most common causes include, in decreasing incidence: uterine atony, retained products of conception, placental abnormalities, uterine inversion, uterine rupture, genital tract trauma and coagulopathies . An initial physical exam is needed to identify atony and to repair lower genital tract trauma, as well as to identify and remove any retained placental tissue.
Uterine atony refers to a floppy, flaccid uterus, one in which the myometrium is unable to contract effectively after the expulsion of the placenta leading to hemorrhage. Bimanual uterine massage should be performed, with one hand in the vagina, and the other hand placed on the abdomen at the level of the uterine fundus to stimulate uterine contraction.
Retained uterine products are the most common cause of delayed (occurring more than 24 hours after birth) post partum hemorrhage . In normal circumstances, uterine contractions expel the placenta within a few minutes of childbirth. The placenta is then examined, to ensure it is intact. Predisposed risk for retained uterine products includes history of previous curettage, cesarean section, multiple births or endometrial infection or injury .
If the placenta has not been delivered within 15-30 minutes of childbirth or in cases suspicious for retained placental fragments, the placenta must be retrieved . Golan and colleagues, 1983 , showed success of medical management by injecting 10 IU of oxytocin directly into the umbilical vein. Providing bleeding cessation in 10 of 10 patients treated for PPH due to delayed (>30 min) expulsion of placenta. If this umbilical vein injection is bypassed, or not successful, adequate regional anesthesia or general anesthesia should be ensured; current hemostatic parameters should be reassessed with cross-matched blood available, broad spectrum antibiotics administered and an oxytocin drip (40 IU oxytocin in 500 mL of 0.9% saline, at 125 mL/hr) should be started before attempting to remove retained uterine products. The best way to remove retained products is to approach transvaginally, finding the plane between the placenta and uterine wall then gently separate the placental parts from the uterus sweeping the surgeon's fingers in a side-to-side motion. After this has been completed, the uterine cavity should again be checked to ensure it is empty .
Injuries to the genital tract may produce severe bleeding, a quantity that may be unexpected to the inexperienced. Optimal repair includes correct positioning of the patient to allow for adequate vision and access of surgical instruments. In order to gain effective control of the bleeding, the injured area should be sutured, starting at the apex of the tear. If the apex cannot be reached, the suture should be started as close to the apex as possible, then, once the remainder of the tear has been approximated, place traction to reach the previously hidden apex. If there is extensive trauma to the vaginal wall, with multiple lacerations, bruising and oozing repairs, vaginal packing to provide hemostasis should be placed and maintained for 12-24 hours . Vaginal packing consists of gauze tape, roller gauze or gauze 4 × 4's that are tied end to end, placed loosely at first, then more tightly in subsequent layers using a ring or dressing forceps to create a mass the size of a softball. It is important to ensure foley catheter has been placed to allow an outlet for urination in addition to monitoring of urine output .
Failure of Hemorrhage Control
If postpartum hemorrhage has not been controlled at this point the patient should be emergently moved to the labor and delivery OR suite, notifying the anesthesia provider, the blood bank (of the possibility for massive transfusion protocol) and the following staff, if available: Staff General/Trauma surgeon, senior general surgery residents, the patient's nurse and any available nurse's assistants. Activation of the hospital's massive transfusion protocol specifies a predetermined ratio of PRBCs, thawed plasma, cryoprecipitate, platelets, and recombinant factor VIIa (rFVIIa) in hopes of preventing the early coagulopathy seen in trauma patients receiving 10 or more units of packed red blood cells . Many hospitals have created their own unique protocol to address this aspect of management, such as Vanderbilt University Medical Center, which has published their hospital's guidelines: for the first round of transfusion, 10 units of non-irradiated, uncrossed packed red blood cells, 4 units of AB negative plasma and 2 units of single donor platelets are sent by the blood bank; then for continued hemorrhage, bundles of blood products are sent containing 6 units of non-irradiated PRBCs, 4 units of thawed plasma and 2 units of single donor platelets . in obstetrical patients if transfusion is needed before type specific or crossmatched blood can be obtained, if possible type-O, Rh-negative blood should be utilized because of future risk of Rh sensitization; however if not readily available Rh-positive blood should not be withheld if clinically required. The surgeon must be aware that hemolytic transfusion reactions with emergency non typed blood can reach up to 5% .
Escalated Medical Management
If initial interventions fail to control postpartum hemorrhage, a stepwise progression of medical therapy is available using uterotonics to facilitate contraction of the uterus.
The first agent used is oxytocin. In the United States, oxytocin is typically administered after delivery of the placenta dosed at 10-20 units in 1000 mL of crystalloid solution, given intravenously (IV) and titrated to an in infusion rate that achieves adequate uterine contractions. Less commonly, it can be given intramuscularly (IM) or intrauterine (IU). It is common practice to double the oxytocin in PPH, i.e., 40 units in 1 L, and safety/efficacy has been documented up to 80 units per liter of crystalloid . Oxytocin is not bolused, as boluses can cause hypotension. Excessive oxytocin can cause water intoxication, as it resembles antidiuretic hormone.
If there is not adequate uterine tone with oxytocin, the second line agent used will depend on the medications' side effects and contraindications. Two classes of drugs are available: ergot alkaloids (methylergonovine) or prostaglandins (PGF2α, PGE1, and PGE2). Methylergonovine may be used, dosed as 0.2 mg IM and repeated 2-4 hrs later, as long as the patient does not have hypertension or preeclampsia. If the patient has contraindications to methylergonovine or if the hemorrhage is still non-responsive, 250 μg of 15-methylprostagandin F2α may be injected intramuscularly (IM) up to 3 times at 15-20 minute intervals (maximum dose 2 mg) . Appropriate injection points include thigh, gluteal muscle or directly into the myometrium. While these drugs are commonly administered without incident, the patient should be monitored for a reflexive response of hypotension and circulatory collapse . Response usually occurs within minutes with clinical trials showing a 75% response rate to a single dose of 15-methylprostaglandin F2α increasing to a 95% response after three doses . PGF2α is contraindicated in asthma and hypertension patients, as it can cause significant broncho-constriction and elevated blood pressures. It's side effect profile includes diarrhea, nausea, vomiting and fever. More recently, PGE1 (misoprostol) has shown promise and is being used more frequently, due to its lack of contraindications and minimal side effects of tachycardia and fever. (A single dose of 1000 μg may be administered rectally . A final option is PGE2, which is administered 20 mg rectally with repetition, as necessary every 2 hours. Unfortunately, it has an unfavorable side effect profile that includes fever, chills, nausea, vomiting, diarrhea and headaches .
Although not commonly described in discussions of post-partum hemorrhage management, Lurie and colleagues, 1997 , described the cessation of uterine bleeding after injecting 1 mL (5IU) of vasopressin in 19 mL of normal saline subendometrially. Throughout these treatments, staff should continue to administer bimanual uterine compressions . If all of the medical treatments have failed and all other causes of post-partum hemorrhage have been excluded, treatment should progress to surgical options.
Pressure and tamponade are commonly used methods to control bleeding. Uterine packing applies these principles, making it a popular technique for over a century, whereas balloon tamponade is a more recent development.
Uterine packing is a quick, viable option to create hemostasis. Critics' concerns address the large quantities of blood that may be absorbed by the pack or hidden behind the pack before hospital staff can recognize that bleeding has continued. It may be performed in one of two acceptable transvaginal methods; both using non-medicated, dry gauze. The first technique of uterine packing employs a tubular packer, such as the Holmes or Torpin packer. The cervix is exposed, then grasped securely with a sponge forceps or a tenaculum. The stylet or plunger of the packer is used to insert the gauze into the uterus until it is packed tightly all the way to the introitus. In the second technique, a packing or dressing forceps is used to introduce the gauze into the uterus, using short strokes and taking care not to remove the tips of the forceps until the uterus and vagina are tightly packed. Broad-spectrum antibiotics should always be used prophylactically to prevent complications from sepsis. The pack can be left in place and managed in the same fashion as intraabdominal packing for abdominal damage control. To remove the pack, the patient should first receive an anxiolytic, such as 10 mg of IV diazepam before slowly pulling the gauze out. Oxytocin, administered for 12-24 hours after the pack is removed, provides adequate muscle contraction, thus preventing the re-initiation of bleeding .
An alternate method is balloon tamponade. Balloon tamponade has been used in different scenarios of uncontrolled bleeding, including esophageal varices, massive bladder hemorrhage and bleeding associated with prostatectomy. The general idea is to insert a sterilized balloon into the uterine cavity, then fill the balloon with warm water to see if additional pressure can control the patient's hemorrhage. Four methods have been described in the literature.
In the original description of the 'tamponade test', a Sengstaken-Blakemore tube is used, prepared by cutting off the portion of the tube distal to the stomach balloon. Two pair of sponge forceps are needed: the first, used to grasp the anterior lip of the cervix and facilitates the placement of the balloon into the uterine cavity, held by the second pair of forceps. Warm saline was used to fill the balloon until it was visible at the cervical canal - using approximately 50-300 mL of fluid [27–29].
Johanson, et al, 2001 , described the same process using a Rusch balloon catheter, a type of urologic hydrostatic balloon catheter. The patient is placed in the Lloyd Davies position and a weighted speculum is used to insert the balloon into the uterine cavity. The balloon is inflated through the drainage port, using approximately 400-500 mL of warm saline.
Bakri, et al., 2001 , developed 'the tamponade balloon' specifically for lower-uterine post-partum hemorrhage. The patient is placed in the lithotomy, or 'frog-leg' position and the distal end of the balloon catheter is inserted into the uterus through the cervix. A speculum is used to place vaginal packing, then the balloon is inflated with 250-500 mL of warm water. A Foley catheter may be used for this maneuver, using the largest caliber Foley catheter after first removing the portion of the catheter beyond the balloon attachment. The catheter is introduced through the cervix to the uterus, and the balloon is filled with adequate fluid to provide a tamponade effect - 5 to 40 mL has been described as an appropriate amount. Clamping the catheter will provide additional pressure.
A successful tamponade demonstrates decreased or minimal bleeding after balloon inflation, thus terminating the need for surgical treatment. To help maintain the placement of the balloon, the upper vagina is packed with roller gauze. The previously placed Foley catheter should be kept in place to facilitate bladder drainage. Additionally, the previously started oxytocin infusion should be maintained for 12-24 hours and broad spectrum antibiotics are continued for three days to decrease the patient's risk for sepsis. After 24 hours of monitoring without subsequent bleeding, hemostatic interventions are removed in a step-wise manner. First the balloon is deflated but left in place. If no bleeding is seen after 30 minutes of observation, the oxytocin infusion is stopped and the patient is again monitored for 30 minutes. The balloon and vaginal packing may be removed if all bleeding has ceased .
For surgical management, the patient is generally placed under general anesthesia in the Lloyd Davies position (lithotomy position with trendelenberg) ; although Pal and colleagues, 2003 , describe success with supine positioning. If child birth occurred via caesarean section, and there is ongoing bleeding, one can directly carry out the surgical maneuvers described below through the open incision. If PPH occurs in the recovery room after a completed cesarean section, the patient should be emergently returned to the OR, and the skin incision is re-opened. If PPH occurs following a vaginal delivery a Pfannenstiel or midline incision is utilized to rapidly access the uterus through the abdomen . Once access is attained, multiple surgical options are available, to include undersuturing venous sinuses, a variety of compression suture techniques and selective arterial ligation.
One of the simplest surgical solutions to stop post-partum hemorrhage is the undersuture. The thinness of the tissue in the lower uterine segment and the narrowed section of the cervical canal often causes difficulty, due to the friability of the area. Because of this, full-thickness sutures work best. Horizontal sutures are placed across and below the bleeding points. It is important not to obliterate the OS or the cervical canal to allow residual blood to drain through the vagina .
Compression sutures are a recent innovation used to address post-partum hemorrhage. The original technique was the B-Lynch suture, created by Dr. B-Lynch, a British Obstetrician/Gynecologist . Adaptations of this technique include the square suture and the modified B-Lynch sutures, created by Drs. Cho (2000)  and Hayman (2002) , respectively. Since these are recent techniques, published evidence is mostly limited to case reports and series. In his 2007 article, Baskett offers results of a 7-year study of compression sutures, all done at the time of cesarean delivery, showing that compression sutures were able to control bleeding in 23 of 28 (82%) of women, thereby preventing hysterectomy. Of these women, seven were able to have subsequent uncomplicated term pregnancies .
A No. 2 chromic catgut suture is used to enter the uterus 3 cm from the right lateral border and 3 cm below the right lower edge of the uterine incision. The suture is passed through the uterine cavity, exiting 3 cm above and 4 cm medial to the lateral border at the upper margin of the uterus. The suture is run externally over the anterior, fundal, and then posterior surfaces of the uterus in a plane 3-4 cm medial to the right cornual border before the needle is reinserted at a point in the posterior wall that corresponds to the anterior uterine incision. A surgical assistant may apply bimanual uterine compression to aid in pulling the suture under moderate tension.
Once the right side of the uterus has been compressed by the first half of the B-Lynch suture, the needle is passed laterally to the left side of the cavity, exiting the posterior wall of the uterus in a horizontal plane to the posterior wall entry point. The suture is threaded over the posterior, fundal and anterior surfaces in a plane 3-4 cm medial to the left cornual border before re-entering the uterine cavity anteriorly at a point 3 cm above the uterine incision and 4 cm from the lateral border; effectively completing the first half of the stitch in the opposite direction. Again, it is useful to have an assistant present to apply bimanual uterine compression while the stitch is pulled under moderate tension. The suture is passed inferior to the uterine incision, and then emerges through the anterior uterine wall at a point 3 cm below the uterine incision and 3 cm medial to the lateral border of the uterine wall. The stitch is completed by tying the right and left sides of the suture on the anterior surface of the uterus inferior to the uterine incision. The uterine incision, followed by the abdominal wall is then closed similar to the closure of a cesarean section.
Modified B-Lynch Suture
To perform this stitch, a straight needle with a 2-Dexon suture is inserted into the uterus above the bladder reflection 2 cm medial to the lateral border of the lower uterine segment and 3 cm below the left lower edge of the uterine incision. The needle is then threaded through to the posterior wall of uterus, then returned from posterior to anterior wall at a point 1-2 cm medial to the first pass of the suture and both ends were tied on the anterior aspect of the anterior wall. The stitch is then repeated on the same horizontal plane on the right side of the lower uterine segment .
To control bleeding in the body of the fundus, the modified brace suture is added. A No. 2 chromic cat gut suture is placed in the anterior wall of the uterus and passed through the posterior wall of the uterus, just superior to the isthmic-cervical apposition suture. The ends of the suture are tied using a three-knot technique at the fundus, 3-4 cm medial to the cornua while external compression is performed by an assistant. An identical stitch is performed on the contralateral side. If this doesn't control the bleeding, horizontal compression sutures may be added to the modified B-Lynch sutures .
Throughout this technique, it is important to keep the lower cervical segment and the OS patent in order to allow drainage of blood from the cavity. Afterwards, the bladders, ureters and bowel must be inspected to exclude trauma .
Uterine Artery Ligation
Uterine artery ligation is one of the easiest and most effective surgical measures to control PPH. It is relatively safe, can be performed easily, and allows for future childbearing. The uterine arteries supply 90% of the blood to the uterus; therefore, ligation drastically decreases blood flow and subsequent blood loss . Despite this percentage, the surgeon should not worry about resultant uterine necrosis, as adequate blood supply is still available .
This procedure is performed as follows. First the vesicouterine fold of peritoneum is identified and incised transversely in order to mobilize the bladder inferiorly. Next, the uterus is externalized for full exposure in order to identify an avascular window in the broad ligament. If an avascular area is not readily apparent, the surgeon may use the lateral border of the uterus. A No. 1 chromic catgut or polyglycolic suture should be used to make a posterior to anterior stitch through the myometrium at a site 2-3 cm medial to the uterine artery. The needle is returned anterior to posterior through the avascular window at a site just below the level of the utero-vesical peritoneal reflection. The two ends are tied securely, completing the ligation. The ureters, bladder and bowel should all be inspected for inadvertent trauma before repeating the procedure on the contralateral uterine artery .
Utero-Ovarian Artery Anastomosis Ligation
Internal Iliac Artery (Hypogastric Artery) Ligation
Internal Iliac artery ligation is the next step in treatment. Bilateral ligation of the vaginal branch decreases pulse pressure in the distal arteries by 85%, improving. Unfortunately this procedure has a low success rate, estimated at 40%, mostly attributed to the late stage at which the ligation is attempted and that it is frequently complicated by hematoma formation and tissue edema that obscure the anatomy .
The steps to perform the internal iliac artery ligation are as follows. An 8-10 cm incision is made in the peritoneum parallel and lateral to the ureter which opens the retroperitoneal space. The peritoneal flap with the ureter is retracted medially so that the internal iliac artery may be dissected out and the posterior branch can be identified. Next, the posterior branch of the internal iliac artery is separated from the internal iliac vein and a right-angled clamp is used to place two ligatures around each of the vessels. It is important to check the external iliac artery to confirm that adequate pulse pressure is present for perfusion of distal branches. It is also important to inspect the ureters for signs of trauma. Once these are completed, the steps are repeated on the contralateral side . Please refer to Figure 4 for an anatomic depiction. Complications of this procedure can be severe, including ischemic damage to the pelvis, decreased blood flow to the gluteal muscles (if the ligation is performed above the branch point of the posterior branch, or injury to the iliac vessels .
Hysterectomy is the last line of treatment available for treating post-partum hemorrhage attributed to uterine bleeding. It is only used for hemorrhage unresponsive to other management attempts, as it removes the patient's option to bear additional children . Recently, the subtotal hysterectomy has become a preferable procedure in this situation. It is quicker, associated with less blood loss, reduced intra- & postoperative complications and reduced need for further blood transfusion . However, if the bleeding source is found in the lower segment of the uterus, a total hysterectomy is needed . Unfortunately, both subtotal and total hysterectomy completed for post-partum hemorrhage is associated with high rates of maternal mortality .
A midline or transverse incision is used to open the abdomen. The bowels are packed out of the operating field to protect them from injury. The round ligaments are identified bilaterally, then clamped, divided and ligated. Next, the posterior leaf of the broad ligament is identified. It is perforated just inferior to the Fallopian tubes so that the utero-ovarian ligament and ovarian vessel can be clamped, divided and ligated. This step is repeated on the opposite side. Now, the broad ligament is detached: the posterior leaf is divided up to the uterosacral ligaments, and the anterior leaf is divided down to the superior margin of the bladder. The bladder is mobilized by making an incision in the vesicouterine fold of the peritoneum then bluntly dissecting the fascia away. By dissecting with a downward placement of tissue, the ureters should be pushed out of the operating field and out of harm's way. Next, the uterine vessels are identified bilaterally. Each is clamped close to the uterus so they may be divided and ligated. If a subtotal hysterectomy is adequate, the procedure is completed by transecting the cervix and closing the residual stump with interrupted stitches. If a total hysterectomy is necessary, the bladder is dissected away from the cervix until the superior portion of the vagina can be identified. The cardinal ligaments are located, again clamping each before their division and ligation. Finally, the cervix is detached from the vagina by cutting as close to the cervical margin as possible. The cardinal ligaments are used to secure the lateral vaginal fornices prior to suturing the vaginal vault closed .
Selective Arterial Embolization
Selective arterial embolization has been well documented throughout the literature as a means of controlling post-partum hemorrhage. It is recommended as an alternative to surgical therapy with success rates of 85-100%. The uterine artery is the most commonly embolized vessel, followed by the pudendal, hypogastric, obturator, vaginal and cervical arteries . Unfortunately, the utility of selective arterial embolization is often limited to a small number of hospitals where a trained, available interventional radiologist is present .
Local anesthesia or an epidural should be administered prior to the initiation of embolization by cannulization of the femoral artery . The catheter is advanced under fluoroscopy proximal to the point of bleeding and an angiogram is done to confirm the bleeding source. The bleeding vessel(s) is/are catheterized to control the hemorrhage . During the embolization, an absorbable gel sponge, usually reabsorbed within 10 days, may be used . Vessels should always be embolized bilaterally, as a unilateral embolization can increase the risk of further bleeding by secondary recanalization of collateral branches .
The surgeon may change to a consultant role once control of the bleeding has occurred and the patient has been stabilized. The patient should be admitted to an intensive care unit for close monitoring until stability has been assured.
The views expressed in this presentation are those of the authors and do not reflect the official policy of the Department of the Army, Department of the Navy, the Department of Defense or the United States Government.
We are a military service member (or employee of the US Government). This work was prepared as part of our official duties. Title 17 U.S.C. 105 provides that 'Copyright protection under this title is not available for any work of the United States Government.' Title 17 U.S.C. 101 defines a U.S. Government work as a work prepared by a military service member or employee of the US Government as part of that person's official duties.
I/We certify that all individuals who qualify as authors have been listed; each has participated in the conception and design of this work, the analysis of data (when applicable), the writing of the document, and the approval of the submission of this version; that the document represents valid work; that if we used information derived from another source, we obtained all necessary approvals to use it and made appropriate acknowledgements in the document; and that each takes public responsibility for it.
Source of Support: No grants, equipment or drugs were used for the writing of this article.
- Pritchard JA, Baldwin RM, Dickey JC: Blood volume changes in pregnancy and the puerperium. II. Red blood cell loss and changes in apparent blood volume during and following vaginal delivery, cesarean section and cesarean section plus total hysterectomy. Am J Obstet Gynecol. 1962, 84: 1271-1282.Google Scholar
- Hofmeyr GJ, Mohlala BK: Hypovolaemic Shock. Bailleres Best Pract Res Clin Obstet Gynaecology. 15: 645-662. 10.1053/beog.2001.0205.Google Scholar
- Abou Zahr C, Royston E: Global Mortality: Global Factbook. 1991, Geneva: World Health OrganisationGoogle Scholar
- Stones RW, Paterson CM, Saunders NJ: Risk Factors for Major Obstetric Haemorrhage. European Journal of Obstetrics, Gynecology & Reproductive Biology. 1993, 48: 15-18. 10.1016/0028-2243(93)90047-G.View ArticleGoogle Scholar
- American College of Obstetrics and Gynecology practice bulletin: Clinical Management Guidelines for Obstetricians-Gynecologists number 76, October 2006: Postpartum Hemorrhage. Obstet Gynecol. 2006, 108: 1039-1047.View ArticleGoogle Scholar
- Combs CA, Murphy EL, Laros RK: Factors Associated with Postpartum Hemorrhage with Vaginal Birth. Obstetrics & Gynecology. 1991, 77: 69-76.Google Scholar
- Combs CA, Murphy EL, Laros RK: Factors Associated with Hemorrhage in Cesarean Deliveries. Obstetrics & Gynecology. 1991, 77: 77-82.Google Scholar
- Prasertcharoensuk W, Swadpanich U, Lumbiganon P: Accuracy of the Blood Loss Estimation in the Third Stage of Labor. International Journal of Gynaecology & Obstetrics. 2000, 71: 69-70. 10.1016/S0020-7292(00)00294-0.View ArticleGoogle Scholar
- Tsu VD: Postpartum Haemorrhage in Zimbabwe: a Risk Factor Analysis. British Journal of Obstetrics & Gynaecology. 1993, 100: 327-333. Prasertcharoensuk W, Swadpanich U & Lumbiganon P. (2000) Accuracy of the Blood Loss Estimation in the Third Stage of Labor. International Journal of Gynaecology & Obstetrics. 71:69-70View ArticleGoogle Scholar
- Eichinger S: D-Dimer Testing in Pregnancy. Pathophysiology of Haemostasis and Thrombosis. 2004, 33: 327-329. 10.1159/000083822.View ArticleGoogle Scholar
- Tamizian O, Arulkumaran S: the Surgical Management of Post-Partum Haemorrhage. Best Practice & Research Clinical Obstetrics and Gynaecology. 2002, 16 (1): 81-98. 10.1053/beog.2002.0257.View ArticleGoogle Scholar
- Roberts WE: Emergent Obstetric Management of Postpartum Hemorrhage. Obstetrics and Gynecology Clinics of North America. 1995, 22 (2): 283-302.PubMedGoogle Scholar
- Bonnar J: Major Obstetric Hemorrhage. Baillieres Best Practice & Research. Clinical Obstetrics & Gynaecology. 2000, 14 (1): 1-18. 10.1053/beog.1999.0060.View ArticleGoogle Scholar
- Moore M, Morales JP, Sabharwal T, Oteng-Ntim E, O'Sullivan G: Selective Arterial Embolisation: A First Line Measure for Obstetric Haemorrhage. International Journal of Obstetric Anesthesia. 2008, 17: 70-73. 10.1016/j.ijoa.2007.01.015.View ArticlePubMedGoogle Scholar
- Golan A, Lidor AL, Wexler S, David MP: A New Method in the Management of Retained Placenta. American Journal of Obstetrics and Gynaecology. 1983, 146 (6): 708-709.View ArticleGoogle Scholar
- Hughey MJ: Postpartum Hemorrhage. Military Obstetrics & Gynecology. 2006, Brookside Associates, [http://www.brooksidepress.org/Products/Military_OBGYN/Home.htm]Google Scholar
- O'Keeffe T, Refaai M, Tchorz K, Forestner JE, Sarode R: A Massive Transfusion Protocol to Decrease Blood Component Use and Costs. Archives of Surgery. 2008, 143 (7): 686-691. 10.1001/archsurg.143.7.686.View ArticlePubMedGoogle Scholar
- Gunter OL, Au BK, Isbell JM, Mowery NT, Young PP, Cotton BA: Optimizing Outcomes in Damage Control Resuscitation: Identifying Blood Product Ratios Associated With Improved Survival. The Journal of Trauma. 2008, 65: 527-534. 10.1097/TA.0b013e3181826ddf.View ArticlePubMedGoogle Scholar
- Fuller AJ, Bucklin B: Blood Component Therapy in Obstetrics. Obstetrics and Gynecology Clinics of North America. 2007, 34: 443-458. 10.1016/j.ogc.2007.06.003.View ArticlePubMedGoogle Scholar
- Munn MB, Owen J, Vincent R: Comparison of Two Oxytocin Regimens to Prevent Uterine Atony at Cesarean Delivery: A Randomized Controlled Trial. Obstet Gynecol. 2001, 98: 386-10.1016/S0029-7844(01)01479-X.View ArticlePubMedGoogle Scholar
- Oyelese Y, Scorza WE, Mastrolia R: Postpartum Hemorrhage. Obstetrics and Gynecology Clinics of North America. 2007, 34: 421-441. 10.1016/j.ogc.2007.06.007.View ArticlePubMedGoogle Scholar
- Gilstrap LC, Ramin SM: Postpartum Hemorrhage. Clinical Obstetrics and Gynecology. 1994, 37 (4): 824-830.View ArticlePubMedGoogle Scholar
- O'Brien P, El Refaey H, Gordon A, Geary M, Rodeck CH: Rectally Administered Misoprostol for the Treatment of Post-Partum Haemorrhage Unresponsive to Oxytocin and Ergometrine: A Descriptive Study. Obstetrics and Gynaecology. 1998, 92 (2): 212-214.View ArticleGoogle Scholar
- Gulmezoglu AM: Prostaglandins for Prevention of Postpartum Hemorrhage. Cochrane Database Syst Rev. 2000, CD000494-Google Scholar
- Lurie S, Appleman Z, Katz Z: Subendometrial Vasopressin to Control Intractable Placental Bleeding. The Lancet. 1997, 349: 698-10.1016/S0140-6736(05)60133-X. Drucker M, Wallach RC: 1979, Uterine Packing: A Reappraisal. The Mount Sinai Journal of Medicine. 46(2). 191-194View ArticleGoogle Scholar
- Drucker M, Wallach RC: Uterine Packing: A Reappraisal. The Mount Sinai Journal of Medicine. 1979, 46 (2): 191-194.Google Scholar
- Katesmark M, Brown R, Raju KS: Successful Use of Sengstaken-Blakemore Tube to Control Massive Post-Partum Haemorrhage. British Journal of Obstetrics and Gynaecology. 1994, 101: 259-260.View ArticlePubMedGoogle Scholar
- Chan C, Razvi K, Tham FK, Arulkumaran S: The Use of Sengstaken-Blakemore Tube to Control PostPartum Haemorrhage. International Journal of Obstetrics and Gynaecology. 1997, 58: 251-252. 10.1016/S0020-7292(97)00090-8.View ArticleGoogle Scholar
- Condous GS, Arulkumaran S, Symonds I, Chapman R, Sinha A, Razvi K: the 'Tamponade Test' in the Management of Post-Partum Haemorrhage. Obstetrics and Gynecology. 2003, 101 (4): 767-772. 10.1016/S0029-7844(03)00046-2.View ArticlePubMedGoogle Scholar
- Johanson R, Kumar M, Obhrai M, Young P: Management of Massive Post-Partum Haemorrhage: Use of a Hydrostatic Balloon Catheter to Avoid Laparotomy. British Journal of Obstetrics and Gynaecology. 2001, 108: 420-422. 10.1016/S0306-5456(00)00102-9.View ArticlePubMedGoogle Scholar
- Bakri YN, Amri A, Abdul Jabbar F: Tamponade-Balloon for Obstetrical Bleeding. International Journal of Gynaecology and Obstetrics. 2001, 72 (2): 139-142. 10.1016/S0020-7292(01)00395-2.View ArticleGoogle Scholar
- Pal M, Biswas AK, Bhattacharya SM: B-Lynch Brace Suturing in Primary Post-Partum Hemorrhage During Cesarean Section. Journal of Obstetrics and Gynaecology. 2003, 29 (5): 317-320.Google Scholar
- B-Lynch C, Coker A, Lawal AH, Abu J, Cowen MJ: the B-Lynch Surgical Technique for the Control of Massive Postpartum Haemorrhage: An Alternative to Hysterectomy? Five Cases Reported. British Journal of Obstetrics and Gynaecology. 1997, 104: 372-375.View ArticlePubMedGoogle Scholar
- Cho JH, Jun HS, Lee CN: Hemostatic Suturing Technique for Uterine Bleeding During Cesarean Delivery. Obstetrics & Gynecology. 2000, 96 (1): 129-131. 10.1016/S0029-7844(00)00852-8.View ArticleGoogle Scholar
- Hayman RG, Arulkumaran S, Steer PJ: Uterine Compression Sutures: Surgical Management of Postpartum Hemorrhage. Obstetrics and Gynecology. 2002, 99 (3): 502-506. 10.1016/S0029-7844(01)01643-X.View ArticlePubMedGoogle Scholar
- Baskett TF: Uterine Compression Sutures for Postpartum Hemorrhage. Obstetrics & Gynecology. 2007, 110 (1): 68-71.View ArticleGoogle Scholar
- Soumunkiran A, Ozdemir I, Demiraran Y, Yucel O: B-Lynch Suture after the Failure of Hypogastric Artery Ligation to Control Post-Partum Hemorrhage due to Placenta Increta in a Patient with the Factor V Leiden Mutation. The Journal of Obstetrics and Gynaecology Research. 2007, 33 (4): 557-560. 10.1111/j.1447-0756.2007.00567.x.View ArticleGoogle Scholar
- El-Hamamy E, B-Lynch C: A Worldwide Review of the Uses of the Uterine Compression Suture Techniques as Alternative to Hysterectomy in the Management of Severe Post-Partum Haemorrhage. Journal of Obstetrics and Gynaecology. 2005, 25 (2): 143-149. 10.1080/01443610500040752.View ArticlePubMedGoogle Scholar
- B-Lynch C: B-Lynch Brace Suture (Technical Details). [http://www.cblynch.com/video.html]
- Yucel O, Ozdemir I, Yucel N, Soumunkiran A: Emergency Peripartum Hysterectomy: A 9-Year Review. Archives of Gynecology and Obstetrics. 2006, 274: 84-87. 10.1007/s00404-006-0124-4.View ArticlePubMedGoogle Scholar
- Chanrachakul B, Chaturachinda K, Phuapradit W, Roungsipragarn R: Cesarean & Post-Partum Hysterectomy. International Journal of Gynaecology and Obstetrics. 1996, 50: 257-262.Google Scholar
- Vegas G, Illescas T, Munoz M, Perez-Pinar A: Selective Pelvic Arterial Embolization in the Management of Obstetric Hemorrhage. European Journal of Obstetrics, Gynecology and Reproductive Biology. 2006, 127 (1): 68-72. 10.1016/j.ejogrb.2005.09.008.View ArticleGoogle Scholar
- Oei PL, Chua S, Tan L, Ratnam SS, Arulkumaran S: Arterial Embolization for Bleeding Following Hysterectomy for Intractable Post-Partum Hemorrhage. International Journal of Gynecology & Obstetrics. 1998, 62: 83-86. 10.1016/S0020-7292(98)00071-X.View ArticleGoogle Scholar
- Yamashita Y, Harada M, Yamamoto H, Miyazaki T, Takahashi M, Miyazaki K, Okamura H: Transcatheter Arterial Embolization of Obstetric & Gynaecological Bleeding: Efficacy & Clinical Outcome. British Journal of Radiology. 1994, 67 (798): 530-534. 10.1259/0007-1285-67-798-530.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.